Clinical Trials Browser

Urinary Bladder Neoplasms

NCT07097142 2026-05-04

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Phase 3 Recruiting

486 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Phase 1/2 Recruiting

40 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03348969 2026-03-03

NICSA

Phase 4 Completed

120 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07189793 2025-09-24

OHAI-NMIBC-01

Phase 2 Not yet recruiting

106 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT05024734 2025-03-11

GAIN INST

Phase 2 Recruiting

34 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06227065 2024-01-26

POLO

Phase 2 Not yet recruiting

28 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02948543 2023-06-18

BCG+MM

Phase 3 Unknown

501 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02695771 2023-04-21

BIC

Phase 3 Completed

101 enrolled 11 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Phase 2 Completed

2 enrolled 8 charts

Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT03844256 2022-08-12

CRIMI

Phase 1/2 Recruiting

50 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02070120 2020-03-19

CALIBER

Phase 2 Unknown

82 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03790384 2018-12-31

MITOBCG

Phase 4 Unknown

140 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03694535 2018-10-03

Intravesical Thermochemotherapy With Mitomycin-c

Phase NA Completed

44 enrolled

Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT02311101 2015-12-03

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

Phase 1 Completed

18 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00974818 2015-11-20

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Phase 3 Terminated

50 enrolled 7 charts

Genitourinary

Urinary Bladder Neoplasms

NCT01442519 2011-09-28

BCG/EMDA-MMC

Phase 3 Completed

212 enrolled

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

NICSA

OHAI-NMIBC-01

GAIN INST

POLO

BCG+MM

BIC

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

CRIMI

CALIBER

MITOBCG

Intravesical Thermochemotherapy With Mitomycin-c

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

BCG/EMDA-MMC